BWM
ONC

Bullock Wealth Management’s BeOne Medicines Ltd ONC Stock Holding History

Bullock Wealth Management’s Portfolio ONC Stock Details ONC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-72
Closed -$17.7K – 662
2025
Q2 		$17.7K Hold
72
– – 0.01% 335
2025
Q1 		$19.5K Hold
72
– – 0.01% 313
2024
Q4 		$13.3K Buy
+72
New +$14.7K 0.01% 362

Other funds holding ONC

BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $484B AUM 34.9% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
HA
HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return
Temasek Holdings
Temasek Holdings Singapore $37.3B AUM 12.6% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
SL
Siren LLC Greenwich, Connecticut $4.94B AUM 244.43% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Bullock Wealth Management's ONC Position: Q3 2025 in Review

Bullock Wealth Management sold out of BeOne Medicines Ltd (ONC) in Q3 2025, closing a stake of 72 shares — an estimated $17.7K sold.

Bullock Wealth Management first reported a position in ONC in Q4 2024 and held it in 3 quarters. The position peaked at $19.5K in Q1 2025. 266 funds tracked by Wall St. Rank hold ONC as of Q3 2025.

  • Bullock Wealth Management reported no remaining BeOne Medicines Ltd position as of Q3 2025 after selling out during the quarter.
  • Bullock Wealth Management sold 72 BeOne Medicines Ltd shares in Q3 2025, an estimated $17.7K.
  • Bullock Wealth Management first reported a position in BeOne Medicines Ltd in Q4 2024 and held it in 3 quarters.
  • Bullock Wealth Management's BeOne Medicines Ltd position peaked at $19.5K in Q1 2025.
  • 266 funds tracked by Wall St. Rank held BeOne Medicines Ltd as of Q3 2025.

Based on Bullock Wealth Management's 13F filing for Q3 2025, filed 24 Sep 2026.